XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma (clinicaltrials.gov) - Dec 19, 2020 - P2; N=70; Not yet recruiting; Sponsor: Chemlmmune Therapeutics LLC
Clinical • New P2 trial • Asthma • Immunology • Respiratory Diseases
|